Yazar "Demirkan, Fatih" için listeleme

Toplam kayıt 3, listelenen: 1-3

Ibrutinib: From Molecule to Medicine

Ayyildiz, Orhan; Demirkan, Fatih; Goker, Hakan; Haznedaroglu, Ibrahim C.; Ilhan, Osman; Kaynar, Leyla G.; Vural, Filiz (Akad Doktorlar Yayinevi, 2014)

Bruton's tyrosine kinase (BTK) inhibitor Ibrutinib (PCI-32765) is a novel targeted-therapeutic agent modulating BCR, which serves as a covalent irreversible inhibitor of BTK. Ibrutinib significantly alters the composition ...
Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

Kater, Arnon; Panagiotis, Panayiotidis; Aktan, Melih; Arslan, Onder; Demirkan, Fatih; Enggaard, Lisbeth; Forconi, Francesco (Taylor & Francis Ltd, 2020)

…
The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz, Serdal; Medeni, Serife Solmaz; Demirkan, Fatih; Besisik, Sevgi Kalayoglu; Dadin, Senem Altay; Cagliyan, Gulsum Akgun; Ozatli, Duzgun (Pergamon-Elsevier Science Ltd, 2019)

Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain ...